Our research findings have been published in several respected academic journals, and we have submitted a number of international patent applications. These developments have been noticed and reported on by a variety of media outlets, both local and international, such as Science Daily, Xinhua News Agency, ScienceNet.cn, China News Service, Los Angeles Times, and Australian Associated Press.
The project ”Development and application of New Reprogramming Technology” applied by iCamuno Joint International team was funded by NHMRC
2024.12.19MORE
iCamuno Biotech’s joint project was selected for the 2025 annual ”Sharp Troop Leader + X” Science and Technology Plan of Zhejiang Province.
2024.12.10MORE
iCamuno Biotech has made it onto the 2024 GEI China Potential Unicorn Enterprises List.
2024.12.09MORE
iCamuno Biology and Mr. CAI Lei jointly build a joint laboratory of ”ALS stem cell disease model and drug screening”* and work together to accelerate the research of ALS
2024.07.16MORE
Dr. Liu Xiaodong* founder of iCamuno Biology* was selected as one of the ”35 Technological Innovators Under the age of 35” by MIT Science and Technology Forum in 2023.
2024.07.11MORE
iCamuno joined hands with the Second Hospital of Zhejiang University to start clinical research cooperation on Parkinson’s disease cell therapy
